يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Puerto, Gloria Mercedes"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Biomedica; Vol. 44 No. 2 (2024); 277-280 ; Biomédica; Vol. 44 Núm. 2 (2024); 277-280 ; 2590-7379 ; 0120-4157

    مصطلحات موضوعية: tuberculosis

    وصف الملف: application/pdf

    Relation: https://revistabiomedica.org/index.php/biomedica/article/view/7553/5515; Puerto GM, Castro CM, Rubio VV, Fadul S, Montes F. Tuberculosis multirresistente en Colombia, 2013-2018: estudio de casos y controles. Biomédica. 2023;43:447-56.; Murillo-Palacios OL. Conceptualización y usos de las categorías etnia y raza en el análisis de salud para población afrocolombiana. Rev Fac Nac Salud Pública. 2023;41:e09. https://doi.org/10.17533/udea.rfnsp.e345481; Peinado J, Lecca L, Jiménez J, Calderón R, Yataco R, et al. Association between overweight/obesity and multidrug-resistant tuberculosis. Rev Peru Med Exp Salud Publica. 2023;40:59-66. https://doi.org/10.17843/rpmesp.2023.401.12138; Osada J, Zavaleta-Oliver JM, Carrillo JS. The correct use of the OR in epidemiological studies. Medicina Interna de México. 2023;39.6:923-4. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2023/mim236j.pdf; https://revistabiomedica.org/index.php/biomedica/article/view/7553

  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Biomedica; Vol. 43 No. 4 (2023); 447-456 ; Biomédica; Vol. 43 Núm. 4 (2023); 447-456 ; 2590-7379 ; 0120-4157

    وصف الملف: application/pdf; text/xml

    Relation: https://revistabiomedica.org/index.php/biomedica/article/view/6842/5326; https://revistabiomedica.org/index.php/biomedica/article/view/6842/5423; World Health Organization. Tuberculosis. Accessed: August 30, 2023. Available from: https://www.who.int/es/news-room/fact-sheets/detail/tuberculosis; World Health Organization. Global Tuberculosis Report 2021. Accessed: August 30, 2023. Available from: https://www.who.int/publications/i/item/9789240037021; World Health Organization. Global Tuberculosis report 2020. Accessed: August 30, 2023. Available from: https://www.who.int/publications/i/item/9789240013131; Instituto Nacional de Salud. Informe de evento. Tuberculosis farmacorresistente, Colombia, 2020. Accessed: August 30, 2023. Available from: http://www.ins.gov.co/buscador-eventos/Informesdeevento/TUBERCULOSIS%20FARMACORRESISTENTE_2020.pdf; Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drugresistant tuberculosis. Cold Spring Harb Perspect Med. 2015;7:1-20. https://doi.org/10.1101/cshperspect.a017863; World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO; 2014. p. 1–452.; Instituto Nacional de Salud. Protocolo de Vigilancia en Salud Pública, Tuberculosis farmacorresistente, código 813. Accessed: June 24, 2023. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/PRO_Tuberculosis_farmacorresistente.pdf; Instituto Nacional de Salud. Ficha de notificación individual – Datos complementarios. Tuberculosis Cod INS 813. Accessed: June 24, 2023. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/813%20Tuberculosis%202023.pdf; Lazcano E, Salazar E, Hernández M. Estudios epidemiológicos de casos y controles. Fundamento teórico, variantes y aplicaciones. Salud Pública Méx. 2001;43:135-50.; Martínez MÁ, Sánchez A, Faulin FJ. Introducción a los modelos multivariables. In: Díaz de Santos SA, editor. Bioestadística amigable. Segunda edición. Madrid: Universidad de Navarra; 2006.; Ministerio de Salud y Protección Social. Resolución 227 de 2020. Lineamientos técnicos y operativos del programa nacional de prevención y control de la tuberculosis. Accessed: August 30, 2023. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%20227%20de%202020.pdf; Ministerio de Salud y Protección Social. Plan estratégico “Hacia el fin de la Tuberculosis”. Colombia 2016-2025. Accessed: August 30, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/INTOR/Plan-estrategico-fin-tuberculosiscolombia-2016-2025.pdf; Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. Multidrug-resistant Mycobacterium tuberculosis, southwestern Colombia. Emerg Infect Dis. 2011;17:1259–62. https://doi.org/10.3201/eid1707.101797; Baya B, Achenbach CJ, Kone B, Toloba Y, Dabitao DK, Diarra B, et al. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. Int J Infect Dis. 2019;81:149-55. https://doi.org/10.1016/j.ijid.2019.02.004; Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, et al. Development of multidrug resistant tuberculosis in Bangladesh: A case-control study on risk factors. PLoS One. 2014;9:e105214. https://doi.org/10.1371/journal.pone.0105214; van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E. The socioeconomic impact of multidrug resistant tuberculosis on patients: Results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. 2016;16:470-83. https://doi.org/10.1186/s12879-016-1802-x; He XC, Zhang XX, Zhao JN, Liu Y, Yu CB, Yang GR, et al. Epidemiological trends of drugresistant tuberculosis in China from 2007 to 2014. Medicine (Baltimore). 2016;95:15-22. https://doi.org/10.1097/md.0000000000003336; Ali MH, Alrasheedy AA, Hassali MA, Kibuule D, Godman B. Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan. Antibiotics (Basel). 2019;8:90-100. https://doi.org/10.3390/antibiotics8030090; Elduma AH, Mansournia MA, Foroushani AR, Ali HMH, Elegail AMA, Elsony A, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: A case-control study. Epidemiol Health. 2019;41:1-9. https://doi.org/10.4178/epih.e2019014; Congreso de la República de Colombia. Ley número 1122 de 2007. Accessed: June 24, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/ley-1122-de-2007.pdf; Departamento Administrativo Nacional de Estadística - DANE. Boletín Técnico, Medición de empleo informal y seguridad social, Trimestre abril - junio 2021 Accessed: June 24, 2023. Available from: https://www.dane.gov.co/files/investigaciones/boletines/ech/ech_informalidad/bol_geih_informalidad_abr21_jun21.pdf; Ministerio de Salud y Protección Social. Política de atención integral en salud “un sistema de salud al servicio de la gente. Accessed: June 24, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/modelo-pais-2016.pdf; Organización Mundial de la Salud. La COVID-19 pone de relieve la necesidad urgente de reactivar los esfuerzos mundiales por acabar con la tuberculosis. Accessed: June 24, 2023. Available from: https://www.who.int/es/news/item/22-03-2021-covid-19-highlights-urgentneed-to-reboot-global-effort-to-end-tuberculosis; Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018;13:e0197737. https://doi.org/10.1371/journal.pone.0197737; Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149-55. https://doi.org/10.1093/ije/dyp308; Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: Evidence from a systematic review and meta-analysis. Syst Rev. 2018;7:161-74. https://doi.org/10.1186/s13643-018-0828-0; Gómez-Gómez A, Magaña-Aquino M, López-Meza S, Aranda-Álvarez M, Díaz-Ornelas DE, Hernández-Segura MG, et al. Diabetes and other risk factors for multi-drug resistant tuberculosis in a Mexican population with pulmonary tuberculosis: Case control study. Arch Med Res. 2015;46:142–8. https://doi.org/10.1016/j.arcmed.2015.01.006; Organización Mundial de la Salud. Diabetes, Colombia 2016, perfil de país. Accessed: February 7, 2023. Available from: https://www.who.int/es/publications/m/item/diabetes-colcountry-profile-colombia-2016; Organización Mundial de la Salud. Diabetes, México 2016, perfil de país. Accessed: August 30, 2023. Available from: https://www.who.int/es/publications/m/item/diabetes-mex-countryprofile-mexico-2016; Caminero JA. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010;14:382-90.; Bergonzoli G, Castellanos LG, Rodríguez R, García LM. Determinants of tuberculosis in countries of Latin America and the Caribbean. Rev Panam Salud Pública. 2016;39:101-5.; Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MHR, Ahmed S, et al. HIV infection and multidrug resistant tuberculosis: A systematic review and meta-analysis. BMC Infect Dis. 2021;21:51-64. https://doi.org/10.1186/s12879-020-05749-2; Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: A systematic review. Thorax. 2006;61:158-163. https://doi.org/10.1136/thx.2005.045963; Departamento Administrativo Nacional de Estadística - DANE. Estadísticas Demografía y Población - Grupos étnicos - Información técnica. Accessed: August 30, 2023. Available from: http://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/grupos-etnicos/informacion-tecnica; Departamento Administrativo Nacional de Estadística - DANE. Encuesta nacional de calidad de vida (ECV) 2018. Accessed: August 30, 2023. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/salud/calidad-de-vida-ecv/encuesta-nacional-de-calidadde-vida-ecv-2018; https://revistabiomedica.org/index.php/biomedica/article/view/6842

  4. 4
    Academic Journal

    المؤلفون: Puerto, Gloria Mercedes

    المصدر: Biomedica; Vol. 43 No. Sp. 2 (2023): Memorias XVIII Encuentro Científico; 16-18 ; Biomédica; Vol. 43 Núm. Sp. 2 (2023): Memorias XVIII Encuentro Científico; 16-18 ; 2590-7379 ; 0120-4157

    مصطلحات موضوعية: public health, salud pública

    وصف الملف: application/pdf

  5. 5
    Electronic Resource

    Additional Titles: Tuberculosis multirresistente en Colombia, 2013-2018: estudio de casos y controles

    المصدر: Biomedica; Vol. 43 No. 4 (2023); 447-456; Biomédica; Vol. 43 Núm. 4 (2023); 447-456; 2590-7379; 0120-4157

    URL: https://revistabiomedica.org/index.php/biomedica/article/view/6842
    https://revistabiomedica.org/index.php/biomedica/article/view/6842/5326
    https://revistabiomedica.org/index.php/biomedica/article/view/6842/5423
    https://revistabiomedica.org/index.php/biomedica/article/view/6842/5326
    https://revistabiomedica.org/index.php/biomedica/article/view/6842/5423
    *ref*/World Health Organization. Tuberculosis. Accessed: August 30, 2023. Available from: https://www.who.int/es/news-room/fact-sheets/detail/tuberculosis
    *ref*/World Health Organization. Global Tuberculosis Report 2021. Accessed: August 30, 2023. Available from: https://www.who.int/publications/i/item/9789240037021
    *ref*/World Health Organization. Global Tuberculosis report 2020. Accessed: August 30, 2023. Available from: https://www.who.int/publications/i/item/9789240013131
    *ref*/Instituto Nacional de Salud. Informe de evento. Tuberculosis farmacorresistente, Colombia, 2020. Accessed: August 30, 2023. Available from: http://www.ins.gov.co/buscador-eventos/Informesdeevento/TUBERCULOSIS%20FARMACORRESISTENTE_2020.pdf
    *ref*/Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drugresistant tuberculosis. Cold Spring Harb Perspect Med. 2015;7:1-20. https://doi.org/10.1101/cshperspect.a017863
    *ref*/World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO; 2014. p. 1–452.
    *ref*/Instituto Nacional de Salud. Protocolo de Vigilancia en Salud Pública, Tuberculosis farmacorresistente, código 813. Accessed: June 24, 2023. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/PRO_Tuberculosis_farmacorresistente.pdf
    *ref*/Instituto Nacional de Salud. Ficha de notificación individual – Datos complementarios. Tuberculosis Cod INS 813. Accessed: June 24, 2023. Available from: https://www.ins.gov.co/buscador-eventos/Lineamientos/813%20Tuberculosis%202023.pdf
    *ref*/Lazcano E, Salazar E, Hernández M. Estudios epidemiológicos de casos y controles. Fundamento teórico, variantes y aplicaciones. Salud Pública Méx. 2001;43:135-50.
    *ref*/Martínez MÁ, Sánchez A, Faulin FJ. Introducción a los modelos multivariables. In: Díaz de Santos SA, editor. Bioestadística amigable. Segunda edición. Madrid: Universidad de Navarra; 2006.
    *ref*/Ministerio de Salud y Protección Social. Resolución 227 de 2020. Lineamientos técnicos y operativos del programa nacional de prevención y control de la tuberculosis. Accessed: August 30, 2023. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%20227%20de%202020.pdf
    *ref*/Ministerio de Salud y Protección Social. Plan estratégico “Hacia el fin de la Tuberculosis”. Colombia 2016-2025. Accessed: August 30, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/INTOR/Plan-estrategico-fin-tuberculosiscolombia-2016-2025.pdf
    *ref*/Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. Multidrug-resistant Mycobacterium tuberculosis, southwestern Colombia. Emerg Infect Dis. 2011;17:1259–62. https://doi.org/10.3201/eid1707.101797
    *ref*/Baya B, Achenbach CJ, Kone B, Toloba Y, Dabitao DK, Diarra B, et al. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. Int J Infect Dis. 2019;81:149-55. https://doi.org/10.1016/j.ijid.2019.02.004
    *ref*/Rifat M, Milton AH, Hall J, Oldmeadow C, Islam MA, Husain A, et al. Development of multidrug resistant tuberculosis in Bangladesh: A case-control study on risk factors. PLoS One. 2014;9:e105214. https://doi.org/10.1371/journal.pone.0105214
    *ref*/van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E. The socioeconomic impact of multidrug resistant tuberculosis on patients: Results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. 2016;16:470-83. https://doi.org/10.1186/s12879-016-1802-x
    *ref*/He XC, Zhang XX, Zhao JN, Liu Y, Yu CB, Yang GR, et al. Epidemiological trends of drugresistant tuberculosis in China from 2007 to 2014. Medicine (Baltimore). 2016;95:15-22. https://doi.org/10.1097/md.0000000000003336
    *ref*/Ali MH, Alrasheedy AA, Hassali MA, Kibuule D, Godman B. Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan. Antibiotics (Basel). 2019;8:90-100. https://doi.org/10.3390/antibiotics8030090
    *ref*/Elduma AH, Mansournia MA, Foroushani AR, Ali HMH, Elegail AMA, Elsony A, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: A case-control study. Epidemiol Health. 2019;41:1-9. https://doi.org/10.4178/epih.e2019014
    *ref*/Congreso de la República de Colombia. Ley número 1122 de 2007. Accessed: June 24, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/ley-1122-de-2007.pdf
    *ref*/Departamento Administrativo Nacional de Estadística - DANE. Boletín Técnico, Medición de empleo informal y seguridad social, Trimestre abril - junio 2021 Accessed: June 24, 2023. Available from: https://www.dane.gov.co/files/investigaciones/boletines/ech/ech_informalidad/bol_geih_informalidad_abr21_jun21.pdf
    *ref*/Ministerio de Salud y Protección Social. Política de atención integral en salud “un sistema de salud al servicio de la gente. Accessed: June 24, 2023. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/modelo-pais-2016.pdf
    *ref*/Organización Mundial de la Salud. La COVID-19 pone de relieve la necesidad urgente de reactivar los esfuerzos mundiales por acabar con la tuberculosis. Accessed: June 24, 2023. Available from: https://www.who.int/es/news/item/22-03-2021-covid-19-highlights-urgentneed-to-reboot-global-effort-to-end-tuberculosis
    *ref*/Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018;13:e0197737. https://doi.org/10.1371/journal.pone.0197737
    *ref*/Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149-55. https://doi.org/10.1093/ije/dyp308
    *ref*/Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: Evidence from a systematic review and meta-analysis. Syst Rev. 2018;7:161-74. https://doi.org/10.1186/s13643-018-0828-0
    *ref*/Gómez-Gómez A, Magaña-Aquino M, López-Meza S, Aranda-Álvarez M, Díaz-Ornelas DE, Hernández-Segura MG, et al. Diabetes and other risk factors for multi-drug resistant tuberculosis in a Mexican population with pulmonary tuberculosis: Case control study. Arch Med Res. 2015;46:142–8. https://doi.org/10.1016/j.arcmed.2015.01.006
    *ref*/Organización Mundial de la Salud. Diabetes, Colombia 2016, perfil de país. Accessed: February 7, 2023. Available from: https://www.who.int/es/publications/m/item/diabetes-colcountry-profile-colombia-2016
    *ref*/Organización Mundial de la Salud. Diabetes, México 2016, perfil de país. Accessed: August 30, 2023. Available from: https://www.who.int/es/publications/m/item/diabetes-mex-countryprofile-mexico-2016
    *ref*/Caminero JA. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010;14:382-90.
    *ref*/Bergonzoli G, Castellanos LG, Rodríguez R, García LM. Determinants of tuberculosis in countries of Latin America and the Caribbean. Rev Panam Salud Pública. 2016;39:101-5.
    *ref*/Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MHR, Ahmed S, et al. HIV infection and multidrug resistant tuberculosis: A systematic review and meta-analysis. BMC Infect Dis. 2021;21:51-64. https://doi.org/10.1186/s12879-020-05749-2
    *ref*/Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: A systematic review. Thorax. 2006;61:158-163. https://doi.org/10.1136/thx.2005.045963
    *ref*/Departamento Administrativo Nacional de Estadística - DANE. Estadísticas Demografía y Población - Grupos étnicos - Información técnica. Accessed: August 30, 2023. Available from: http://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/grupos-etnicos/informacion-tecnica
    *ref*/Departamento Administrativo Nacional de Estadística - DANE. Encuesta nacional de calidad de vida (ECV) 2018. Accessed: August 30, 2023. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/salud/calidad-de-vida-ecv/encuesta-nacional-de-calidadde-vida-ecv-2018

  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المصدر: Biomedica; Vol. 41 No. Sp. 3 (2021): Memorias XVII Encuentro Científico; 21-22 ; Biomédica; Vol. 41 Núm. Sp. 3 (2021): Memorias XVII Encuentro Científico; 21-22 ; 2590-7379 ; 0120-4157

    مصطلحات موضوعية: pandemics, Colombia, pandemia

    وصف الملف: application/pdf

  8. 8
    Academic Journal

    Alternate Title: National Network for Knowledge Management, Research, and Innovation in Tuberculosis in Colombia.
    Rede Nacional de Gestão do Conhecimento, Pesquisa e Inovação em tuberculose na Colômbia.

    المصدر: Pan American Journal of Public Health. 2021, Vol. 45, p1-6. 6p.

    مصطلحات جغرافية: COLOMBIA

    الشركة/الكيان: PAN American Health Organization